
An Emirati medical team won first place in the scientific competition organized by the Scientific Committee of the 11th International Dermatology and Aesthetics Congress (IDEA) in Abu Dhabi.
The winning team included three Emirati female doctors who recently graduated from the dermatology residency program at Rashid Hospital in Dubai: Dr. Fatima Al Qaidi, Dr. Al Reem Al Hosani, and Dr. Aisha Al Shawab.
The team outperformed four other teams representing the Gulf Cooperation Council (GCC) countries. The teams were subjected to a series of medical questions and challenges specializing in diagnosing skin conditions, under the supervision of a scientific jury comprising a select group of experts in the field.
The second day of the conference featured a series of advanced scientific lectures highlighting the latest innovations in dermatology and aesthetics, including the use of artificial intelligence in cyberplastic surgery, treatments enhanced by next-generation technologies, skin rejuvenation using DNA, and regenerative medicine, in addition to the latest skincare trends such as facial treatments derived from salmon semen.
The second day's sessions discussed a number of medical issues, including laser treatment for skin of color and dealing with pigmentation disorders, biological treatments for children and food allergies, and a review of new drugs designed to regenerate nerve cells in Alzheimer's disease.
On the sidelines of the conference, a series of specialized workshops were organized to train doctors on the latest technologies. These included a workshop on the safe use of ultrasound devices in cosmetic injections, another in collaboration with Apple on the use of modern iPhone devices for accurate documentation and diagnosis of skin disease cases, and a training workshop on the use of threads in cosmetic surgery.
The Emirates Society of Dermatology held a meeting to discuss developments in the sector and the latest treatment practices. A session was also dedicated to the Canadian Board of Dermatology, which addressed the latest developments in safe and future treatments for dermatology and cosmetic medicine.